Atomera Incorporated vs Enveric Biosciences Inc — how do they compare? Atomera Incorporated trades at $6.48 (market cap $247.40M), while Enveric Biosciences Inc trades at $1.25 (market cap $5.32M). The key difference: Atomera Incorporated is far larger — about 46.5× Enveric Biosciences Inc's market cap, and Atomera Incorporated is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ATOM | ENVB | |
|---|---|---|
Market Cap | $247.40M | $5.32M |
Sector | Technology | Health |
52-Week High | $12.11 | $17.40 |
52-Week Low | $1.99 | $1.28 |
Enterprise Value | $207.61M | $408.82K |
Signals from Pluang's Aura AI — not financial advice
ATOM trades at $6.25, down 5.73% over 24 hours, reflecting a bearish technical outlook with negative earnings trends. The company reported a net loss of $20.17 million in 2025 on minimal revenue of $65,000, with profitability metrics deeply negative. Recent news highlights Atomera's focus on semiconductor technology advancements, including GaN-on-Silicon collaborations, but financial performance remains a significant concern.
The outlook is cautious due to persistent losses and weak revenue, though analyst consensus is unanimously bullish with a 100% buy rating. Key risks include execution challenges in monetizing technology and high cash burn. Upside depends on successful commercialization of its semiconductor IP, but current fundamentals suggest high volatility and substantial shareholder risk.
No Aura AI signal available yet.
Trailing returns across standard periods
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →